BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22946426)

  • 1. Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".
    Zarogoulidis P; Kontakiotis T; Zarogoulidis K
    Ther Deliv; 2012 Aug; 3(8):919-21. PubMed ID: 22946426
    [No Abstract]   [Full Text] [Related]  

  • 2. Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.
    Zarogouldis P; Karamanos NK; Porpodis K; Domvri K; Huang H; Hohenforst-Schimdt W; Goldberg EP; Zarogoulidis K
    Int J Mol Sci; 2012; 13(9):10828-10862. PubMed ID: 23109824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.
    Densmore CL
    Curr Cancer Drug Targets; 2003 Aug; 3(4):275-86. PubMed ID: 12871058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes.
    Gautam A; Waldrep JC; Kleinerman ES; Xu B; Fung YK; T'Ang A; Densmore CL
    Methods Mol Med; 2003; 75():607-18. PubMed ID: 12407767
    [No Abstract]   [Full Text] [Related]  

  • 5. Aerosol gene therapy.
    Gautam A; Waldrep JC; Densmore CL
    Mol Biotechnol; 2003 Jan; 23(1):51-60. PubMed ID: 12611269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and evolving treatment methods for pulmonary metastases.
    Putnam JB
    Semin Thorac Cardiovasc Surg; 2002 Jan; 14(1):49-56. PubMed ID: 11977017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized Medications for Gene and Peptide Therapy.
    Laube BL
    Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery for tuberculosis: is inhaled therapy the key to success?
    Traini D; Young PM
    Ther Deliv; 2017 Oct; 8(10):819-821. PubMed ID: 28944739
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to inhaled gene therapy of obstructive lung diseases: A review.
    Kim N; Duncan GA; Hanes J; Suk JS
    J Control Release; 2016 Oct; 240():465-488. PubMed ID: 27196742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for lung cancer--an application for cationic lipid-mediated gene delivery?
    Scheule RK
    J Natl Cancer Inst; 1998 Aug; 90(15):1118-9. PubMed ID: 9701356
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled chemotherapy in lung cancer: safety concerns of nanocomplexes delivered.
    Zarogoulidis P; Giraleli C; Karamanos NK
    Ther Deliv; 2012 Sep; 3(9):1021-3. PubMed ID: 23035587
    [No Abstract]   [Full Text] [Related]  

  • 13. Delivering gene therapy.
    Seymour LW
    J Drug Target; 2002 Mar; 10(2):91. PubMed ID: 12074544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
    Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
    Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled delivery of aerosolized cyclosporine.
    Corcoran TE
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1119-27. PubMed ID: 16997418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-based delivery systems for antiangiogenic therapy.
    Machluf M; Carroll RS
    Biotechnol Genet Eng Rev; 2003; 20():183-95. PubMed ID: 14997852
    [No Abstract]   [Full Text] [Related]  

  • 17. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of therapeutic synthetic polymers for drug and gene delivery.
    Pardridge WM
    Drug Discov Today; 2002 Nov; 7(22):1120-1. PubMed ID: 12546851
    [No Abstract]   [Full Text] [Related]  

  • 19. Camptothecins and lung cancer: improved delivery systems by aerosol.
    Koshkina NV; Waldrep JC; Knight V
    Curr Cancer Drug Targets; 2003 Aug; 3(4):251-64. PubMed ID: 12871056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC conditionally approves lung cancer gene therapy.
    Jenks S
    J Natl Cancer Inst; 1994 Jul; 86(13):964-5. PubMed ID: 8007017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.